<DOC>
	<DOCNO>NCT00245674</DOCNO>
	<brief_summary>During study efficacy safety profile evaluate use amisulpride form solution schizophrenic patient acute episode . The main purpose study observe anti-psychotic effect amisulpride solution first day acute episode schizophrenia .</brief_summary>
	<brief_title>SOLIACS : Solian Solution Acute Setting</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<criteria>schizophrenic inpatient acute episode age 18 65 year write informed consent pregnancy breastfeed breast cancer , prolactinoma , pheochromocytoma hypersensitivity amisulpride one excipients contraindication use amisulpride per SmPC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>